Sterile processing

Your trusted partner in aceptic fill-finish

With extensive experience in aseptic processing and sterile manufacturing, our team can support you with aseptic and terminally sterilized small volume liquids for parenteral, ocular and pulmonary delivery.

Purpose-built facility

A new purpose-built 7,000sqft facility, designed specifically in line with the revised EU GMP Annex-1 regulations is due to be completed in Q4 2024.
The state-of-the-art build provides a new service to develop, manufacture, test and fill/finish sterile drug products for biologics and small molecules.
Alongside existing full-service formulation development and quality control labs our team can support your drug development with expertise and speed.

Sterile fill/finish services

Our contract manufacturing capabilities and successful regulatory history supports you in maximising the success of your drug product.
Our sterile processing capabilities include:
Sterile drug products – aseptically prepared and terminally sterilised.
Liquid formulations for parenteral, ocular and pulmonary delivery.
– Wide range of molecules from small molecules to Biologics (including proteins, peptides and mAbs).
Small-scale batch sizes.

Product testing

Our team supports you in every aspect of analytical and microbial testing including the QP release of your final product.
We work to ensure the early identification of lead prototype formulations suitable for clinical testing followed by the development of your product through the product cycle.
Through ASAPprime® our teams generate robust, accelerated stability data, from API drug substance stability to formulation development prototypes and final dosage forms.

Expertise you can trust

Our Leadership Team excels in steering products from pre-clinical to market. This extensive expertise forms the cornerstone of our service to you, ensuring hands-on involvement at every stage and every level of our business.
Full-service offering
Alongside our upcoming aseptic capabilities, our formulation development across a broad range of dosage forms, clinical trial supply, and niche-scale commercial manufacturing for non-sterile dosage forms provides accessible scale-up and unparalleled project delivery.

Want to find out more about our sterile processing capability?

Keep up-to-date with our sterile facility journey.
Speak to our team to learn more and discuss your future requirements.